NVDAMillionaire Posted - 4 days ago

$EXPO Exponent Inc. (NASDAQ:EXPO): Leveraging Multidisciplinary Expertise to Navigate Complex Challenges https://beyondspx.com/article/exponent-inc-nasdaq-expo-leveraging-multidisciplinary-expertise-to-navigate-complex-challenges

txbondman Posted - 5 days ago

bot $ACLS at 69.77; bot $EXPO at 89.57; bot $PLUS at 74.16; bot $UNP at 225.07;

Estimize Posted - 1 week ago

Wall St is expecting 0.40 EPS for $EXPO Q4 [Reporting 01/30 AMC] http://www.estimize.com/intro/expo?chart=historical&metric_name=eps&utm_co

smartkarma Posted - 1 month ago

$EXPO | Exponent Inc's New Game-Changing Strategies: Multidisciplinary Problem Solving at Its Best! "Exponent Inc.’s third quarter 2024 financial results demonstrate both resilience and constraints in the context of evolving market dynamics." - Baptista Research (Baptista Research) Read more: https://www.smartkarma.com/insights/exponent-inc-s-new-game-changing-strategies-multidisciplinary-problem-solving-at-its-best

insiderbuyingselling Posted - 1 month ago

$EXPO new insider selling: 14000 shares. http://insiderbuyingselling.com/?t=EXPO

insiderbuyingselling Posted - 1 month ago

$EXPO new insider selling: 1039 shares. http://insiderbuyingselling.com/?t=EXPO

swingingtech Posted - 2 months ago

$IVOV $CPRI $EXPO $TKO https://wallstreetwaves.com/analysts-forecast-a-10-increase-for-ivov-holdings/

ChessGM Posted - 2 months ago

$EXPO Upcoming earnings alert for 10/24/2024 ChessGM AI Consensus: Bullish (8.0) In recent evaluations of Exponent Inc. (NASDAQ: EXPO), the overall sentiment surrounding the stock has been notably positive. The company has consistently demonstrated strong long-term performance, with shareholders achieving an impressive 11% compound annual growth rate (CAGR) over the past five years. This trend of growth is echoed by the company's recent quarterly results, which have exceeded market expectations, further boosting investor confidence. Notable institutional activities, like Neuberger Berman Group LLC adjusting its stake, signal robust interest from significant players in the market. Moreover, the anticipation surrounding the upcoming earnings announcement on October 24, 2024, adds to the optimistic outlook, as stakeholders prepare for insights into the company’s performance during the third quarter of fiscal year 2024. Looking ahead, Exponent is set to report its third-quarter fiscal year 2024 results on October 24, 2024. Following the market close, key executives will host a conference call to discuss the financial results for the period ending September 27, 2024. This event is likely to provide critical information regarding the company's financial health and future projections, which could further influence investor sentiment and stock performance. Statistics: 6 articles from 5 sources. Fund Activity based on 13F fillings data suggests that funds were net buyers of $EXPO in the previous quarter. Fund: Conestoga Capital Advisors LLC with $262,841,312 MV (market value in $) and ChessGM fund score: 63% Fund: FundSmith LLP with $96,841,482 MV (market value in $) and ChessGM fund score: 77% Fund: Riverbridge Partners LLC with $90,092,434 MV (market value in $) and ChessGM fund score: 66% Follow us! Do not miss other earnings alerts from ChessGM. Disclaimer: This is not an investment advise. We try to draw consensus and may not get all of the calls right. We use various public data sources which may contain inaccurate or dated information.

WeeklyTrader Posted - 2 months ago

Let’s keep it real about $EXPO's performance! RSI: 56.93% 50-day MA: $107.86 200-day MA: $93.64

WeeklyTrader Posted - 2 months ago

Who's got their eye on $EXPO’s dip? RSI: 56.2% 50-day MA: $107.67 200-day MA: $93.52

smartkarma Posted - 3 months ago

$EXPO | Exponent Inc.: Expanding Market Opportunities in Emerging Technologies! "Exponent Inc.'s Q2 2024 financial results reveal a mixed performance amid market challenges and strategic adaptations aimed at aligning the company’s operational model" - Baptista Research (Baptista Research) Read more: https://www.smartkarma.com/insights/exponent-inc-expanding-market-opportunities-in-emerging-technologies

StockInvest_us Posted - 3 months ago

Signal alert: $EXPO - GoldenStar https://stockinvest.us/l/cKCbUf9Y8J

StockInvest_us Posted - 3 months ago

Signal alert: $EXPO - GoldenStar https://stockinvest.us/l/2HS9zWpDRc

StockInvest_us Posted - 4 months ago

Signal alert: $EXPO - GoldenStar https://stockinvest.us/l/fJ6pT0nG4n

StockInvest_us Posted - 4 months ago

Signal alert: $EXPO - GoldenStar https://stockinvest.us/l/fOkg7oYm2w

StockInvest_us Posted - 4 months ago

Signal alert: $EXPO - GoldenStar https://stockinvest.us/l/75Socc0sw4

insiderbuyingselling Posted - 4 months ago

$EXPO new insider selling: 40662 shares. http://insiderbuyingselling.com/?t=EXPO

G101SPM Posted - 4 months ago

$EXPO $103.64 ask. COVED SHORT/TAKE PROFITS. DAC (dollar average cost) $105.97 (7.25.24).

insiderbuyingselling Posted - 4 months ago

$EXPO new insider selling: 2206 shares. http://insiderbuyingselling.com/?t=EXPO

NVDAMillionaire Posted - 07/30/24

$EXPO Exponent, Inc. (EXPO): Navigating Complexity, Delivering Sustainable Growth http://beyondspx.com/2024/07/30/exponent-inc-expo-navigating-complexity-delivering-sustainable-growth/

epsguid Posted - 5 months ago

$EXPO reported earnings of $0.57, consensus was $0.50 via @eWhispers #epsbeat http://eps.sh/d/expo

DonCorleone77 Posted - 5 months ago

$EXPO Exponent sees FY24 revenue up low to mid-single digits For the fiscal year 2024 we are raising our revenue and margin guidance. Exponent anticipates: Revenues before reimbursements to grow in the low to mid-single digits; and, EBITDA1 to be 27.5% to 28.0% of revenues before reimbursements. "Exponent thrives in the complexity that abounds in products, technologies and regulations. In this environment of relentless innovation in safety-critical applications, we are focused on fueling the growth engines of the future through expanded capabilities, recruitment of top talent, and development of our exceptional team," Dr. Corrigan concluded.

DonCorleone77 Posted - 5 months ago

$EXPO Exponent sees Q3 EBITDA 26.75%-27.5% of revenues before reimbursements "Our ability to strategically manage resources with market demand drove 75% utilization in the first half of 2024 and significantly expanded net income and EBITDA1 margin. Considering our encouraging performance in the first half of 2024 and our outlook for the remainder of the year, we are raising full year guidance. Both our previous and updated outlook include the impact of an additional week in the fourth quarter of fiscal 2024," stated Richard Schlenker, Executive Vice President and Chief Financial Officer...For the third quarter of 2024, as compared to the same period one year prior, Exponent anticipates: Revenues before reimbursements to be approximately flat; and, EBITDA to be 26.75% to 27.5% of revenues before reimbursements. EBITDA to be 26.75% to 27.5% of revenues

DonCorleone77 Posted - 5 months ago

$EXPO Exponent reports Q2 EPS 57c, consensus 50c Reports Q2 revenue $140.5M, consensus $$130.827M...EBITDA increased to $39.9 M, or 30.2% of revenues before reimbursements, in the second quarter of 2024, as compared to $36.8M or 28.4% of revenues before reimbursements in the second quarter of 2023. ."We are pleased with the outcomes of efforts to align our operating model with market demand, evidenced by net income growth of 14% and expanded EBITDA1 margin on a year-over-year basis. As expected, revenue growth moderated during the quarter due to ongoing headwinds in the consumer electronics and chemicals sectors, and an unusually high hurdle for year-over-year comparisons resulting from approximately 20% growth in our prior-year reactive business. Despite these challenges, our reactive business grew in the mid-single digits fueled by demand across the transportation, utilities and medical device sectors," stated Dr. Catherine Corrigan, President and Chief Executive Officer. "We are encouraged by the market opportunities in this era of accelerating transformation across industries, from groundbreaking technology and data applications in life sciences, to renewables and infrastructure resilience in the energy sector, and electrification and automation of transportation. Exponent remains well positioned to support our clients with vital insights for current challenges, while preparing the path for future innovations," Dr. Corrigan continued.

Stock_Titan Posted - 5 months ago

$EXPO Exponent Reports Second Quarter 2024 Financial Results https://www.stocktitan.net/news/EXPO/exponent-reports-second-quarter-2024-financial-068f57l2b7p3.html

G101SPM Posted - 5 months ago

$EXPO $105.57 bid. SELL SHORT/NEW POSITION carries SPM 87.92 tag to $95.00 in near term.

StockInvest_us Posted - 5 months ago

Signal alert: $EXPO - GoldenStar https://stockinvest.us/l/cp74Oof5kV

Stock_Titan Posted - 5 months ago

$EXPO Exponent to Announce Second Quarter of Fiscal Year 2024 Results and Host Quarterly Conference Call on July 25, 2024 https://www.stocktitan.net/news/EXPO/exponent-to-announce-second-quarter-of-fiscal-year-2024-results-and-53nkw6gavuvp.html

insiderbuyingselling Posted - 6 months ago

$EXPO new insider selling: 7000 shares. http://insiderbuyingselling.com/?t=EXPO

insiderbuyingselling Posted - 6 months ago

$EXPO new insider selling: 7000 shares. http://insiderbuyingselling.com/?t=EXPO